Myasthenia Gravis

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Myasthenia Gravis

Are you interested in exploring ongoing clinical trials for Myasthenia Gravis at the University of Alabama at Birmingham?


Following specialists treat  Myasthenia Gravis. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month





Specialty scores for Myasthenia Gravis


  • Some facts about Myasthenia Gravis

  • Myasthenia Gravis is an autoimmune condition where the body’s immune system damages the receptors that conduct the signals from nerves to muscles. Consequently, the muscle’s response to repeated nerve signals declines, leading to weakness and fatigue. The muscle weakness often first appears in the muscles of the face, neck and jaw. The arm and leg muscles are affected at a later stage. Myasthenia gravis affects about 100 per million people. Women under age of 40 and men over 60 are most commonly affected.